Vendor, Torrance, CA, part of Ingro Finanz AG
Bachem Americas Inc.
UEI ULM6JMNK5L83, CAGE 3FGW9
6 awards and $155,748 obligated between January 24, 2024 and July 30, 2026, 100% under full and open competition, against 5.7 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 6 |
| Delivery Order | 5 |
Hear when Bachem Americas Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Bachem Americas Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $26,400
- Soonest
- March 31, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling medicinal and botanical manufacturing to National Institutes of Health, by dollars.
| US Specialty Formulations LLCAllentown, PA | $71,875 |
| Rotem Inc.Topsfield, MA | $39,445 |
| Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBHRadeberg | $11,210 |
| Concept to Market LLCMonrovia, MD | $0 |
| Regis Technologies Inc.Morton Grove, IL | -$48 |
| United Oxygen Company, Inc.Frederick, MD | -$10,561 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
National Institutes of Health, National Institutes of Health
Award noticeNAICS 325411Anywhere in the US75N95024D00009Awarded to Bachem Americas Inc. for $49,716,679
Posted May 14, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95025F00002Delivery Order, September 25, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Task Order Award. Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances. 3 Year Stability Study ExteNAICS 325411, PSC Q301 | $56,100 |
| 75N95025F00003Delivery Order, September 25, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Task Order Award. Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances. 3-Year Stability Study ExteNAICS 325411, PSC Q301 | $45,200 |
| 75N95020F00001Delivery Order, January 24, 2024, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | Have Bachem Issue Qa Reviewed Coas of GMP Drug Substance PTH-IA and Its Qualitative Reference Standard and Assign a New Retest Date Based onNAICS 325411, PSC AN11 | $28,050 |
| 75N95025F00001Delivery Order, May 8, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Extended Stability Studies of PTH-IANAICS 325411, PSC AN11 | $26,400 |
| 75N95024D00009May 13, 2024, Full and Open Competition, 15 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | Idiq: Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesNAICS 325411, PSC AN11 | $0 |
| 75N95020F00002Delivery Order, September 18, 2025, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2020 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 325411, PSC AN11 | -$1 |
- Places of performance
- California
- Product and service codes
- Q301 Reference Laboratory TestingAN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 9 across 6 awards